(Q34056471)

30 July 2017

1 reference

title

HIV disease: mucocutaneous fungal infections in HIV disease (English)

1 reference

30 July 2017

Johnson RA

1

1 reference

30 July 2017

publication date

1 July 2000

1 reference

30 July 2017

published in

Clinics in Dermatology

1 reference

30 July 2017

volume

18

1 reference

30 July 2017

issue

4

1 reference

30 July 2017

page(s)

411-422

1 reference

Pneumocystis carinii pneumonia and mucosal candidiasis in previously healthy homosexual men: evidence of a new acquired cellular immunodeficiency

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2899%2900136-4

7 January 2021

Hierarchical pattern of mucosal candida infections in HIV-seropositive women

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2899%2900136-4

7 January 2021

Esophageal candidiasis associated with acute infection due to human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2899%2900136-4

7 January 2021

Time from HIV seroconversion to oral candidiasis or hairy leukoplakia among homosexual and bisexual men enrolled in three prospective cohorts.

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2899%2900136-4

7 January 2021

Is vulvovaginal candidiasis an AIDS-related illness?

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2899%2900136-4

7 January 2021

Opportunistic candidal infections in patients infected with human immunodeficiency virus: prevention issues and priorities

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2899%2900136-4

7 January 2021

HIV infection in children

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2899%2900136-4

7 January 2021

Fungemia in children infected with the human immunodeficiency virus: new epidemiologic patterns, emerging pathogens, and improved outcome with antifungal therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2899%2900136-4

7 January 2021

Prophylaxis with nystatin pastilles for HIV-associated oral candidiasis

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2899%2900136-4

7 January 2021

Randomized trial of itraconazole oral solution for oropharyngeal candidiasis in HIV/AIDS patients

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2899%2900136-4

7 January 2021

Use of terbinafine in HIV-positive subjects: pilot studies in onychomycosis and oral candidiasis.

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2899%2900136-4

7 January 2021

A randomized, double-blind comparison of itraconazole oral solution and fluconazole tablets in the treatment of esophageal candidiasis

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2899%2900136-4

7 January 2021

Risk factors for fluconazole-resistant candidiasis in human immunodeficiency virus-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2899%2900136-4

7 January 2021

Fluconazole-resistant candidosis in an HIV cohort.

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2899%2900136-4

7 January 2021

Patterns of fluconazole susceptibility in isolates from human immunodeficiency virus-infected patients with oropharyngeal candidiasis due to Candida albicans

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2899%2900136-4

7 January 2021

Infection due to fluconazole-resistant Candida in patients with AIDS: prevalence and microbiology

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2899%2900136-4

7 January 2021

A randomized trial comparing fluconazole with clotrimazole troches for the prevention of fungal infections in patients with advanced human immunodeficiency virus infection. NIAID AIDS Clinical Trials Group

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2899%2900136-4

7 January 2021

Weekly fluconazole for the prevention of mucosal candidiasis in women with HIV infection. A randomized, double-blind, placebo-controlled trial. Terry Beirn Community Programs for Clinical Research on AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2899%2900136-4

7 January 2021

Seborrheic Dermatitis and Butterfly Rash in AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2899%2900136-4

7 January 2021

Seborrheic-like dermatitis of acquired immunodeficiency syndrome. A clinicopathologic study

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2899%2900136-4

7 January 2021

Onychomycosis and AIDS. Clinical and laboratory findings in 62 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2899%2900136-4

7 January 2021

Cutaneous disease and drug reactions in HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2899%2900136-4

7 January 2021

Nail changes in patients infected with human immunodeficiency virus. A prospective controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2899%2900136-4

7 January 2021

Prevalence of onychomycosis in patients attending a dermatology clinic in northeastern Ohio for other conditions

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2899%2900136-4

7 January 2021

The prevalence of skin disease in HIV infection and its relationship to the degree of immunosuppression

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2899%2900136-4

7 January 2021

Clinical pearl: proximal white subungual onychomycosis in AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2899%2900136-4

7 January 2021

Nonscalp hair infection caused by Microsporum canis in patient with acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2899%2900136-4

7 January 2021

Unusual Microsporum canis infections in adult HIV patients

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2899%2900136-4

7 January 2021

Scutular favus-like tinea cruris et pedis in a patient with AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2899%2900136-4

7 January 2021

Disseminated dermatophytosis caused by Microsporum gypseum in two patients with the acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2899%2900136-4

7 January 2021

Generalized Chronic Dermatophytosis in Patients With Human Immunodeficiency Virus Type I Infection and CD4 Depletion

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2899%2900136-4

7 January 2021

Disseminated cutaneous fungal infection and AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2899%2900136-4

7 January 2021

Antifungal agents: an overview. Part II.

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2899%2900136-4

7 January 2021

Toenail onychomycosis in patients with acquired immune deficiency syndrome: treatment with terbinafine

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2899%2900136-4

7 January 2021

Terbinafine for the treatment of pedal onychomycosis. A foot closer to the promised land of cured nails?

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2899%2900136-4

7 January 2021

Terbinafine: an update

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2899%2900136-4

7 January 2021

Itraconazole pulse therapy for onychomycosis and dermatomycoses: an overview

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2899%2900136-4

7 January 2021

Intermittent fluconazole dosing in patients with onychomycosis: results of a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2899%2900136-4

7 January 2021

One-week therapy with oral terbinafine in cases of tinea cruris/corporis

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2899%2900136-4

7 January 2021

Once-weekly oral doses of fluconazole 150 mg in the treatment of tinea pedis

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2899%2900136-4

7 January 2021

Cutaneous cladosporiosis as a complication of skin testing in a man positive for human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2899%2900136-4

7 January 2021

Superficial phaeohyphomycosis of the scrotum in a patient with the acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2899%2900136-4

7 January 2021

Fungal infections in HIV-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2899%2900136-4

7 January 2021

Primary prevention of cryptococcal meningitis by fluconazole in HIV-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2899%2900136-4

7 January 2021

Estimation of the prevalence of cryptococcal infection among patients infected with the human immunodeficiency virus in New York City

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2899%2900136-4

7 January 2021

Epidemiology of cryptococcosis in France: a 9-year survey (1985-1993). French Cryptococcosis Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2899%2900136-4

7 January 2021

Cutaneous Cryptococcus infection and AIDS. Report of 12 cases and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2899%2900136-4

7 January 2021

Cutaneous manifestations of disseminated cryptococcosis

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2899%2900136-4

7 January 2021

Bonsai tree: Risk factor for disseminated sporotrichosis

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2899%2900136-4

7 January 2021

Primary cutaneous aspergillosis near central venous catheters in patients with the acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2899%2900136-4

7 January 2021

Invasive aspergillosis in patients with AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2899%2900136-4

7 January 2021

Aspergillus species colonization and invasive disease in patients with AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2899%2900136-4

7 January 2021

Prospective study of histoplasmosis in patients infected with human immunodeficiency virus: incidence, risk factors, and pathophysiology

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2899%2900136-4

7 January 2021

Disseminated African histoplasmosis in a Congolese patient with AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2899%2900136-4

7 January 2021

Cutaneous disseminated histoplasmosis in AIDS patients in south Florida

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2899%2900136-4

7 January 2021

Infection due to Penicillium marneffei, an emerging pathogen: review of 155 reported cases

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2899%2900136-4

7 January 2021

Case-control study of risk factors for Penicillium marneffei infection in human immunodeficiency virus-infected patients in northern Thailand

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2899%2900136-4

7 January 2021

Disseminated Penicillium marneffei infection in southeast Asia

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2899%2900136-4

7 January 2021

10.1016/S0738-081X(99)00136-4

Identifiers

DOI

1 reference

30 July 2017

1 reference